Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
49.41
+3.13 (6.76%)
At close: Jun 27, 2025, 4:00 PM
49.36
-0.05 (-0.10%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $586.01M in the quarter ending March 31, 2025, with 110.67% growth. This brings the company's revenue in the last twelve months to $1.78B, up 85.99% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$1.78B
Revenue Growth
+85.99%
P/S Ratio
7.46
Revenue / Employee
$1,090,014
Employees
1,637
Market Cap
11.06B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 685.09B |
Costco Wholesale | 268.78B |
PepsiCo | 91.52B |
The Procter & Gamble Company | 83.93B |
Unilever | 62.91B |
Anheuser-Busch InBev | 58.85B |
The Coca-Cola Company | 46.89B |
Philip Morris International | 38.39B |
HIMS News
- 22 hours ago - HIMZ: Buy For Short-Term Gains On Hims & Hers Health, But Be Wary Of The Risks - Seeking Alpha
- 1 day ago - Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura - Business Wire
- 2 days ago - HIMS SECURITIES: Lose Money on Hims & Hers Health, Inc. (NYSE:HIMS)? Contact BFA Law about the Pending Securities Fraud Investigation - GlobeNewsWire
- 2 days ago - Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman - PRNewsWire
- 2 days ago - After Its Biggest Drop Ever - Benzinga
- 2 days ago - HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 3 days ago - Hims & Hers: Panic Sell Or Opportunistic Buy? - Seeking Alpha
- 3 days ago - Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact - Business Wire